BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36416214)

  • 1. SOX3 duplication in a boy with 46,XX ovotesticular disorder of sex development and his 46,XX sister with atypical genitalia: Probable germline mosaicism.
    de Oliveira FM; Barros BA; Dos Santos AP; Campos NLV; Mazzola TN; Filho PL; Andrade LALA; Guaragna MS; de Mello MP; Guerra-Junior G; Vieira TAP; Maciel-Guerra AT
    Am J Med Genet A; 2023 Feb; 191(2):592-598. PubMed ID: 36416214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 46,XX ovotesticular DSD associated with a SOX3 gene duplication in a SRY-negative boy.
    Grinspon RP; Nevado J; Mori Alvarez Mde L; Del Rey G; Castera R; Venara M; Chiesa A; Podestá M; Lapunzina P; Rey RA
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):673-5. PubMed ID: 27260338
    [No Abstract]   [Full Text] [Related]  

  • 3. A Duplication Upstream of SOX9 Associated with
    Mengen E; Kayhan G; Kocaay P; Uçaktürk SA
    J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):308-314. PubMed ID: 31476840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are NR5A1 Variations a Frequent Cause of 46,XX Ovotesticular Disorders of Sex Development? Analysis from a Single Center and Systematic Review.
    Barros BA; Guaragna MS; Fabbri-Scallet H; Palandi de Mello M; Guerra-Júnior G; Maciel-Guerra AT
    Sex Dev; 2022; 16(4):242-251. PubMed ID: 36657429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome sequencing identifies a cryptic SOX9 regulatory element duplication underlying a case of 46,XX ovotesticular difference of sexual development.
    Qian Z; Grand K; Freedman A; Nieto MC; Behlmann A; Schweiger BM; Sanchez-Lara PA
    Am J Med Genet A; 2021 Sep; 185(9):2782-2788. PubMed ID: 34050715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 46, XX Ovotesticular Disorder of Sex Development With Xq27.1q27.2 Duplication Involving the
    Zhuang J; Chen C; Li J; Jiang Y; Wang J; Wang Y; Zeng S; Lin Y; Xie Y
    Front Pediatr; 2021; 9():682846. PubMed ID: 34178900
    [No Abstract]   [Full Text] [Related]  

  • 7. Duplication of SOX3 in an SRY-negative 46,XX male with prostatic utricle: case report and literature review.
    Wei J; Liu C; Zhang M; Liu S; Fu J; Lin P
    BMC Med Genomics; 2022 Sep; 15(1):188. PubMed ID: 36064700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duplication of SOX9 is not a common cause of 46,XX testicular or 46,XX ovotesticular DSD.
    Seeherunvong T; Ukarapong S; McElreavey K; Berkovitz GD; Perera EM
    J Pediatr Endocrinol Metab; 2012; 25(1-2):121-3. PubMed ID: 22570960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial deletion of DMRT1 causes 46,XY ovotesticular disorder of sexual development.
    Ledig S; Hiort O; Wünsch L; Wieacker P
    Eur J Endocrinol; 2012 Jul; 167(1):119-24. PubMed ID: 22573722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 46,XX Ovotesticular Disorder of Sex Development Likely Caused by a Steroidogenic Factor-1 (NR5A1) Variant.
    Swartz JM; Ciarlo R; Guo MH; Abrha A; Weaver B; Diamond DA; Chan YM; Hirschhorn JN
    Horm Res Paediatr; 2017; 87(3):191-195. PubMed ID: 27855412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The smallest dislocated microduplication of Xq27.1 harboring
    Oroz M; Vičić A; Požgaj Šepec M; Karnaš H; Stipančić G; Stipoljev F
    J Pediatr Endocrinol Metab; 2023 Jan; 36(1):86-90. PubMed ID: 36189645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duplication of SOX9 associated with 46,XX ovotesticular disorder of sex development.
    López-Hernández B; Méndez JP; Coral-Vázquez RM; Benítez-Granados J; Zenteno JC; Villegas-Ruiz V; Calzada-León R; Soderlund D; Canto P
    Reprod Biomed Online; 2018 Jul; 37(1):107-112. PubMed ID: 29673731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovotesticular disorder of sexual development and a rare 46,XX/47,XXY karyotype.
    Ozsu E; Mutlu GY; Cizmecioglu FM; Ekingen G; Muezzinoglu B; Hatun S
    J Pediatr Endocrinol Metab; 2013; 26(7-8):789-91. PubMed ID: 23612643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testis development in the absence of SRY: chromosomal rearrangements at SOX9 and SOX3.
    Vetro A; Dehghani MR; Kraoua L; Giorda R; Beri S; Cardarelli L; Merico M; Manolakos E; Parada-Bustamante A; Castro A; Radi O; Camerino G; Brusco A; Sabaghian M; Sofocleous C; Forzano F; Palumbo P; Palumbo O; Calvano S; Zelante L; Grammatico P; Giglio S; Basly M; Chaabouni M; Carella M; Russo G; Bonaglia MC; Zuffardi O
    Eur J Hum Genet; 2015 Aug; 23(8):1025-32. PubMed ID: 25351776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadoblastoma and Papillary Tubal Hyperplasia in Ovotesticular Disorder of Sexual Development.
    Şimşek E; Binay Ç; Demiral M; Tokar B; Kabukçuoğlu S; Üstün M
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):351-5. PubMed ID: 27087521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation Patterns of SOX3, SOX9, and WNT4 Genes in Gonads of Dogs with XX (SRY-Negative) Disorder of Sexual Development.
    Salamon S; Flisikowski K; Switonski M
    Sex Dev; 2017; 11(2):86-93. PubMed ID: 28365713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female-to-male sex reversal associated with unique Xp21.2 deletion disrupting genomic regulatory architecture of the dosage-sensitive sex reversal region.
    Dangle P; Touzon MS; Reyes-Múgica M; Witchel SF; Rajkovic A; Schneck FX; Yatsenko SA
    J Med Genet; 2017 Oct; 54(10):705-709. PubMed ID: 28483799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duplication of The
    Tasic V; Mitrotti A; Riepe FG; Kulle AE; Laban N; Polenakovic M; Plaseska-Karanfilska D; Sanna-Cherchi S; Kostovski M; Gucev Z
    Balkan J Med Genet; 2019 Jun; 22(1):81-88. PubMed ID: 31523625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRY-negative 46,XX testicular/ovotesticular DSD: Long-term outcomes and early blockade of gonadotropic axis.
    Lambert S; Peycelon M; Samara-Boustani D; Hyon C; Dumeige L; Peuchmaur M; Fiot E; Léger J; Simon D; Paye-Jaouen A; Bouligand J; Siffroi JP; Carel JC; McElreavey K; El Ghoneimi A; Brachet C; Bouvattier C; Martinerie L
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):667-676. PubMed ID: 33296530
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.